OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk Factors Associated with the Severity of COVID-19
Martono Martono, Fitri Ayu Fatmawati, Sri Mulyanti
Malaysian Journal of Medical Sciences (2023) Vol. 30, Iss. 3, pp. 84-92
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms
Marília Inês Móvio, Giovana Waner Carneiro de Almeida, Isabella das Graças Lopes Martines, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 161-161
Open Access | Times Cited: 6

Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways
Aishwarya Jaiswal, Sanah Shrivastav, Hemant R. Kushwaha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Investigating the association between major dietary patterns and disease outcomes in diabetic and non-diabetic patients with COVID-19: a cross-sectional study
Atefeh Amrollahi, Zahra Hariri, Tahereh Sabaghian, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access

Cost‐Effectiveness of Nirmatrelvir/Ritonavir in COVID‐19 Patients at High‐Risk for Progression in Spain
José Ramón Azanza Perea, Juan González del Castillo, R Germán Ferrando, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 3
Open Access

Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients
Fernando Rizzello, Elisa Viciani, Paolo Gionchetti, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3

COVID-19 vaccination: 2023 Taiwan Association of Gerontology and Geriatrics (TAGG) consensus statements
Hao Chang, Yi‐Hsuan Lee, Kuo‐Chin Huang, et al.
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 2

Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic
Daniel Gonikman, Dmitrijs Kustovs
Medicina (2023) Vol. 59, Iss. 10, pp. 1810-1810
Open Access | Times Cited: 5

Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease
Chia‐Chen Chen, Chi-Ya Huang, Jheng‐Yan Wu, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-8
Closed Access | Times Cited: 1

Plasma Proteins Associated with COVID-19 Severity in Puerto Rico
Lester J. Rosario-Rodríguez, Yadira M. Cantres-Rosario, Kelvin Carrasquillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5426-5426
Open Access | Times Cited: 1

Polymorphic Variations of ACE2 and TMPRSS2 Genes in Egyptian COVID-19 Patients: Correlation with Disease Severity and Sex-Related Gene Variations
Faten Saad, Ahmed Daif, Moustafa Sakr, et al.
Research Journal of Applied Biotechnology (2024) Vol. 10, Iss. 1, pp. 15-26
Open Access | Times Cited: 1

Comparative effectiveness of bivalent BA.4.5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: a nationwide cohort study
Mie Agermose Gram, Emilia Myrup Thiesson, Nicklas Pihlström, et al.
Journal of Infection (2024) Vol. 89, Iss. 4, pp. 106261-106261
Open Access | Times Cited: 1

DNA Damage in Moderate and Severe COVID-19 Cases: Relation to Demographic, Clinical, and Laboratory Parameters
Tigran Harutyunyan, Anzhela Sargsyan, Lily Kalashyan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10293-10293
Open Access | Times Cited: 1

Hypertension and Cognitive Dysfunction in a Pregnant Rat Model of PE; a Role for CD4+ T Cells
Evangeline Deer, Owen Herrock, Kimberly Simmons, et al.
American Journal of Reproductive Immunology (2024) Vol. 92, Iss. 4
Closed Access | Times Cited: 1

The Antiviral Potential of a Natural Compound for COVID-19: A Review of the Current Findings
Zahra Jafari-Ardakan, Reza Arefnezhad, Fatemeh Rezaei‐Tazangi
Natural Product Communications (2024) Vol. 19, Iss. 10
Open Access | Times Cited: 1

Study of Three Years Follow Up Effect of Covid-19 Infection on Patients on Chronic Kidney Disease
Lamis Khedr, Saeed Wahab Saeed, Rehab Ahmed, et al.
The Egyptian Journal of Hospital Medicine (2024) Vol. 95, Iss. 1, pp. 1926-1931
Open Access

The Impact of Cytokines on Coagulation Profile in COVID-19 Patients: Controlled for Socio-Demographic, Clinical, and Laboratory Parameters
Milica Milentijević, Nataša Katanić, Bojan Joksimović, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1281-1281
Open Access

Prophylactic and therapeutic potential of vitamin D in asthma during the COVID-19 pandemic: the new hope?
Maria Michelle Papamichael, Charis Katsardis
(2024), pp. 245-286
Closed Access

Are Neonatal Birth Weights Reduced in Low-Risk Patients Diagnosed with COVID-19 during Pregnancy?
Hannah S. Foster, Markolline Forkpa, Ximena A. Van Tienhoven, et al.
American Journal of Perinatology (2024)
Closed Access

Long-COVID symptom monitoring: Insights from a two-year telemedicine study
Andrea Foppiani, C Montanari, Sara Zanelli, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307834-e0307834
Open Access

Page 1 - Next Page

Scroll to top